Scripps Research team offers insights that could aid development of phage therapies against Mycobacteria The pathogens which ...

Mycobacteria are the world's most deadly bacteria --c ausing infectious diseases including tuberculosis (TB), which alone kills more than one million people each year. New drugs to fight these ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

The research compares how two bacterial species—Escherichia coli and Mycobacterium tuberculosis—use a ... their effects on protein solution structure, stability, and function.

ROMIE NGUYEN, Graduate Student in UTSA’s Department of Chemistry The treatment of tuberculosis is process that can take approximately eight months to a year, utilizing an antibiotic cocktail that also ...

Tuberculosis lives and thrives in the lungs. When the bacteria that cause the disease ... in detail how they evaporate and what internal structure they leave behind. They observed that the new ...

Mycobacteria are the world’s most deadly bacteria—causing infectious diseases including tuberculosis (TB), which alone kills ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...